Jane Street’s VanEck Biotech ETF BBH Stock Holding History

Jane Street’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-4,400	Closed	-$567K	–	5062
2019 Q2	$567K	Buy	4,400 +2,700	+159%	+$333K	﹤0.01%	3412
2019 Q1	$218K	Buy	+1,700	New	+$215K	﹤0.01%	4567
2017 Q3	–	Sell	-5,000	Closed	-$628K	–	4431
2017 Q2	$628K	Buy	+5,000	New	+$603K	﹤0.01%	2730
2014 Q3	–	Sell	-6,000	Closed	-$572K	–	2532
2014 Q2	$572K	Sell	6,000 -9,500	-61%	-$852K	0.01%	1297
2014 Q1	$1.41M	Buy	+15,500	New	+$1.51M	0.02%	734

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

Jane Street's BBH Position: Q1 2026 in Review

Jane Street sold out of VanEck Biotech ETF (BBH) in Q1 2026, closing a stake of 1,200 shares — an estimated $227K sold.

Jane Street first reported a position in BBH in Q1 2014 and held it in 33 quarters. The position peaked at $4.18M in Q1 2015. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

Jane Street reported no remaining VanEck Biotech ETF position as of Q1 2026 after selling out during the quarter.
Jane Street sold 1,200 VanEck Biotech ETF shares in Q1 2026, an estimated $227K.
Jane Street first reported a position in VanEck Biotech ETF in Q1 2014 and held it in 33 quarters.
Jane Street's VanEck Biotech ETF position peaked at $4.18M in Q1 2015.
112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.